Minsig Choi

1.2k total citations
28 papers, 549 citations indexed

About

Minsig Choi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Minsig Choi has authored 28 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Minsig Choi's work include Pancreatic and Hepatic Oncology Research (16 papers), Cancer Genomics and Diagnostics (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Minsig Choi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (16 papers), Cancer Genomics and Diagnostics (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Minsig Choi collaborates with scholars based in United States, Canada and Saudi Arabia. Minsig Choi's co-authors include Lance K. Heilbrun, Anthony F. Shields, Asfar S. Azmi, Mark M. Zalupski, Jawana M. Lawhorn‐Crews, Raghu Venkatramanamoorthy, Stephen A. Geraci, Mark D. Kochenderfer, Diana F. Hausman and Alexander I. Spira and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The American Journal of Medicine.

In The Last Decade

Minsig Choi

28 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minsig Choi United States 14 360 190 134 104 82 28 549
Prakash Peddi United States 13 282 0.8× 201 1.1× 129 1.0× 125 1.2× 94 1.1× 33 560
Xinmin Zhao China 13 354 1.0× 263 1.4× 259 1.9× 138 1.3× 71 0.9× 47 666
Joaquina Martínez-Galán Spain 14 257 0.7× 236 1.2× 124 0.9× 180 1.7× 81 1.0× 36 544
Maria Vassilakopoulou Greece 14 383 1.1× 267 1.4× 143 1.1× 187 1.8× 159 1.9× 29 790
Mahmoud Ould-Kaci France 10 429 1.2× 125 0.7× 245 1.8× 73 0.7× 53 0.6× 17 540
Elvire Pons‐Tostivint France 13 468 1.3× 238 1.3× 351 2.6× 134 1.3× 87 1.1× 47 764
Jun Sakakibara‐Konishi Japan 15 333 0.9× 368 1.9× 249 1.9× 148 1.4× 38 0.5× 74 745
Ghassan Allo Canada 16 194 0.5× 334 1.8× 172 1.3× 227 2.2× 107 1.3× 29 796
Yaewon Yang South Korea 13 380 1.1× 258 1.4× 141 1.1× 125 1.2× 115 1.4× 54 688
Samith T. Kochuparambil United States 12 247 0.7× 152 0.8× 296 2.2× 164 1.6× 113 1.4× 26 698

Countries citing papers authored by Minsig Choi

Since Specialization
Citations

This map shows the geographic impact of Minsig Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minsig Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minsig Choi more than expected).

Fields of papers citing papers by Minsig Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minsig Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minsig Choi. The network helps show where Minsig Choi may publish in the future.

Co-authorship network of co-authors of Minsig Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Minsig Choi. A scholar is included among the top collaborators of Minsig Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minsig Choi. Minsig Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roa‐Peña, Lucia, Sruthi Babu, Emanuel F. Petricoin, et al.. (2024). Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma. American Journal of Clinical Pathology. 162(3). 314–326. 1 indexed citations
2.
Wrzeszczyński, Kazimierz O., Sadia Rahman, Mayu O. Frank, et al.. (2019). Identification of targetable BRAF ΔN486_P490 variant by whole-genome sequencing leading to dabrafenib-induced remission of a BRAF-mutant pancreatic adenocarcinoma. Molecular Case Studies. 5(6). a004424–a004424. 19 indexed citations
3.
Choi, Minsig, et al.. (2019). <p>Spotlight on liposomal irinotecan for metastatic pancreatic cancer: patient selection and perspectives</p>. OncoTargets and Therapy. Volume 12. 1455–1463. 18 indexed citations
4.
Choi, Minsig, et al.. (2019). Comparison of neoadjuvant and adjuvant therapy for resectable pancreatic cancer using Markov decision modeling.. Journal of Clinical Oncology. 37(4_suppl). 448–448. 1 indexed citations
5.
Gao, Mei, Richard A. Moffitt, Jinha Park, et al.. (2018). Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer. British Journal of Cancer. 120(1). 88–96. 39 indexed citations
6.
Choi, Minsig, et al.. (2017). Challenges in Ras therapeutics in pancreatic cancer. Seminars in Cancer Biology. 54. 101–108. 32 indexed citations
7.
Bowles, Daniel W., Mark D. Kochenderfer, Allen Lee Cohn, et al.. (2016). A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma. Clinical Colorectal Cancer. 15(4). 337–344.e2. 37 indexed citations
8.
Zhang, Yue & Minsig Choi. (2015). Immune Therapy in Pancreatic Cancer: Now and the Future?. Reviews on Recent Clinical Trials. 10(4). 317–325. 14 indexed citations
9.
Konski, André, Joshua E. Meyer, Michael C. Joiner, et al.. (2014). Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer. Radiotherapy and Oncology. 113(1). 35–40. 11 indexed citations
10.
Choi, Minsig, et al.. (2014). Nab-paclitaxel: potential for the treatment of advanced pancreatic cancer. OncoTargets and Therapy. 7. 187–187. 31 indexed citations
11.
12.
Yano, Hiroshi, et al.. (2014). Ipilimumab augments antitumor activity of bispecific antibody-armed T cells. Journal of Translational Medicine. 12(1). 191–191. 26 indexed citations
13.
Salem, Mohamed E., Gregory Dyson, Natalja L. Stanski, et al.. (2014). Clinicopathologic features of patients with KRAS wild-type pancreatic adenocarcinoma.. Journal of Clinical Oncology. 32(3_suppl). 192–192. 2 indexed citations
14.
Salem, Mohamed E., Greg Dyson, Chadi Saad, et al.. (2013). Characteristics of colorectal cancer in patients younger than 40 years compared to older patients.. Journal of Clinical Oncology. 31(4_suppl). 371–371. 1 indexed citations
15.
Meyer, Joshua E., Erin McSpadden, Jonathan D. Cheng, et al.. (2013). Women at increased risk for cardiac toxicity following chemoradiation therapy for esophageal carcinoma. Practical Radiation Oncology. 3(4). e149–e155. 11 indexed citations
16.
Choi, Minsig, Richard D. Kim, & Muhammad Wasif Saif. (2012). What Options Are Available for Refractory Pancreatic Cancer?. PubMed. 13(2). 163–5. 6 indexed citations
17.
Choi, Minsig, et al.. (2011). Surveillance and Monitoring of Adult Cancer Survivors. The American Journal of Medicine. 124(7). 598–601. 29 indexed citations
18.
Choi, Minsig, Lance K. Heilbrun, Raghu Venkatramanamoorthy, et al.. (2010). Using 18F-Fluorodeoxyglucose Positron Emission Tomography to Monitor Clinical Outcomes in Patients Treated With Neoadjuvant Chemo-Radiotherapy for Locally Advanced Pancreatic Cancer. American Journal of Clinical Oncology. 33(3). 257–261. 74 indexed citations
19.
Banerjee, Sanjeev, Minsig Choi, Amro Aboukameel, et al.. (2010). Preclinical Studies of Apogossypolone, a Novel Pan Inhibitor of Bcl-2 and Mcl-1, Synergistically Potentiates Cytotoxic Effect of Gemcitabine in Pancreatic Cancer Cells. Pancreas. 39(3). 323–331. 23 indexed citations
20.
Choi, Minsig, et al.. (2008). Retrospective review of cancer patients ≥80 years old treated with chemotherapy at a comprehensive cancer center. Critical Reviews in Oncology/Hematology. 67(3). 268–272. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prakash Peddi Breakdown of academic impact, for papers by Xinmin Zhao Breakdown of academic impact, for papers by Joaquina Martínez-Galán Breakdown of academic impact, for papers by Maria Vassilakopoulou Breakdown of academic impact, for papers by Mahmoud Ould-Kaci Breakdown of academic impact, for papers by Elvire Pons‐Tostivint Breakdown of academic impact, for papers by Jun Sakakibara‐Konishi Breakdown of academic impact, for papers by Ghassan Allo Breakdown of academic impact, for papers by Yaewon Yang Breakdown of academic impact, for papers by Samith T. Kochuparambil
Rankless by CCL
2026